Organogenesis Holdings Inc Cash Flow-to-Debt Ratio
Organogenesis Holdings Inc cash flow-to-debt ratio. Organogenesis Holdings Inc (ORGO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $3.08 Million could theoretically repay 0% of its total liabilities ($123.85 Million) in one year. Check how aggressively does Organogenesis Holdings Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Organogenesis Holdings Inc (2001–2024)
Cash flow-to-debt ratio of Organogenesis Holdings Inc from 2001 to 2024. Historical debt coverage capacity for Organogenesis Holdings Inc across 11 annual periods. Check ORGO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Organogenesis Holdings Inc Cash Flow-to-Debt Ratio by Year (2001–2024)
Organogenesis Holdings Inc cash flow-to-debt ratio by year from 2001 to 2024. Year-by-year debt coverage analysis for Organogenesis Holdings Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Organogenesis Holdings Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | $14.21 Million | $112.57 Million | ▼ -26.0% |
| 2023 | 0.17x | $30.92 Million | $181.36 Million | ▲ +26.0% |
| 2022 | 0.14x | $24.86 Million | $183.69 Million | ▼ -55.9% |
| 2021 | 0.31x | $61.98 Million | $201.92 Million | ▲ +733.4% |
| 2020 | 0.04x | $5.47 Million | $148.41 Million | ▲ +118.1% |
| 2019 | -0.20x | $-33.53 Million | $165.10 Million | ▲ +61.0% |
| 2018 | -0.52x | $-60.74 Million | $116.64 Million | ▼ -1212.0% |
| 2017 | -0.04x | $-586.60K | $14.78 Million | ▲ +20.0% |
| 2016 | -0.05x | $-562.23K | $11.33 Million | ▲ +99.8% |
| 2015 | -24.48x | $-10.19 Million | $416.43K | ▼ -8145.9% |
| 2001 | -0.30x | $-1.40 Million | $4.70 Million | — |